Official Journal: CADE approves DLM Brasil TI – FIP, Pharma Link Administradora de Redes e Comércio de Produtos Farmacêuticos acquisition deal
MLex Summary: The Brazilian competition authority has approved a proposed acquisition between São Paulo stock-exchange listed DLM Brasil TI – FIP, a private equity fund incorporated in Brazil, and Pharma Link...To view the full article, register now.
Already a subscriber? Click here to view full article